Bionano Genomics (BNGO)
(Delayed Data from NSDQ)
$0.33 USD
0.00 (1.03%)
Updated Oct 16, 2024 04:00 PM ET
After-Market: $0.32 -0.01 (-3.96%) 7:58 PM ET
2-Buy of 5 2
F Value B Growth A Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$0.33 USD
0.00 (1.03%)
Updated Oct 16, 2024 04:00 PM ET
After-Market: $0.32 -0.01 (-3.96%) 7:58 PM ET
2-Buy of 5 2
F Value B Growth A Momentum C VGM
Zacks News
Bionano Genomics, Inc. (BNGO) Reports Q3 Loss, Tops Revenue Estimates
by Zacks Equity Research
Bionano Genomics, Inc. (BNGO) delivered earnings and revenue surprises of -16.67% and 16.38%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Bionano Genomics, Inc. (BNGO) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Bionano Genomics, Inc. (BNGO) delivered earnings and revenue surprises of -20.00% and 16.85%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Bionano (BNGO) to Report Q2 Earnings: What's in the Cards?
by Zacks Equity Research
Bionano Genomics (BNGO) is likely to provide updates on earnings and revenues when it reports second-quarter 2021 results.
Bionano Genomics, Inc. (BNGO) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Bionano Genomics, Inc. (BNGO) closed at $5.87, marking a -1.68% move from the previous day.
Bionano Genomics, Inc. (BNGO) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Bionano Genomics, Inc. (BNGO) closed the most recent trading day at $6.72, moving -1.47% from the previous trading session.
Bionano Genomics, Inc. (BNGO) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Bionano Genomics, Inc. (BNGO) closed at $7.15, marking a -1.38% move from the previous day.
Cummins, Century Aluminum, AMC Entertainment, Ashford Hospitality Trust and Bionano Genomics highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Cummins, Century Aluminum, AMC Entertainment, Ashford Hospitality Trust and Bionano Genomics highlighted as Zacks Bull and Bear of the Day
These 3 Meme Stocks Aren't as Risky as You May Think
by Shuvra Shankar Dey
Solid revenue and earnings growth prospects of AMC, AHT and BNGO make them relatively safer bets despite being favorites of retail trades on the meme frenzy.
Bionano Genomics, Inc. (BNGO) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Bionano Genomics, Inc. (BNGO) delivered earnings and revenue surprises of 0.00% and 13.14%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Implied Volatility Surging for Bionano Genomics (BNGO) Stock Options
by Zacks Equity Research
Investors need to pay close attention to Bionano Genomics (BNGO) stock based on the movements in the options market lately.
Bionano (BNGO) to Report Q1 Earnings: What's in the Cards?
by Zacks Equity Research
Bionano Genomics (BNGO) is expected to provide updates on its earnings and revenues when it reports first-quarter 2021 result.
Bionano Genomics, Inc. (BNGO) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Bionano Genomics, Inc. (BNGO) closed the most recent trading day at $6.97, moving -1.13% from the previous trading session.
Has Bionano Genomics (BNGO) Outpaced Other Medical Stocks This Year?
by Zacks Equity Research
Is (BNGO) Outperforming Other Medical Stocks This Year?
Bionano Genomics, Inc. (BNGO) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Bionano Genomics, Inc. (BNGO) closed at $9.38, marking a -1.57% move from the previous day.
Implied Volatility Surging for Bionano Genomics (BNGO) Stock Options
by Zacks Equity Research
Investors need to pay close attention to Bionano Genomics (BNGO) stock based on the movements in the options market lately.
Why Bionano Genomics (BNGO) Might Surprise This Earnings Season
by Zacks Equity Research
Bionano Genomics (BNGO) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Bionano Genomics, Inc. (BNGO) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Bionano Genomics, Inc. (BNGO) closed at $9.84 in the latest trading session, marking a +1.13% move from the prior day.
Bionano (BNGO) to Report Q4 Earnings: What's in the Offing?
by Zacks Equity Research
Bionano (BNGO) will provide updates on its revenues and earnings when it reports fourth-quarter and full-year 2020 results.
Bionano Genomics, Inc. (BNGO) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Bionano Genomics, Inc. (BNGO) closed at $11.80 in the latest trading session, marking a +1.29% move from the prior day.
Bionano Genomics, Inc. (BNGO) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Bionano Genomics, Inc. (BNGO) closed at $11.85 in the latest trading session, marking a -1.41% move from the prior day.
New Strong Sell Stocks for October 22nd
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today
Bionano Genomics, Inc. (BNGO) Upgraded to Buy: What Does It Mean for the Stock?
by Zacks Equity Research
Bionano Genomics, Inc. (BNGO) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Bionano Genomics, Inc. (BNGO) Upgraded to Buy: Here's Why
by Zacks Equity Research
Bionano Genomics, Inc. (BNGO) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Bionano (BNGO) to Report Q2 Earnings: What's in the Offing?
by Zacks Equity Research
Bionano's (BNGO) sales numbers will be in focus when it reports Q2 results later in the week.
Bionano Genomics, Inc. (BNGO) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Bionano Genomics, Inc. (BNGO) closed the most recent trading day at $0.79, moving +0.25% from the previous trading session.